![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Real-world effectiveness and cost per SVR of
Sofosbuvir/Velpatasvir in chronic hepatitis C treatment / GT3
|
|
|
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Peter Buggisch1, Petar Atanasov2, Karsten Wursthorn1, Albrecht Stoehr1, Jorg Petersen1
1Asklepios Klinik St. Georg, IFI Institut fur Interdisziplinäre Medizin, Hamburg, Germany 2Amaris, London, United Kingdom
![0426171](../images/042617/042617-25/0426171.gif)
![0426172](../images/042617/042617-25/0426172.gif)
![0426173](../images/042617/042617-25/0426173.gif)
![0426174](../images/042617/042617-25/0426174.gif)
![0426175](../images/042617/042617-25/0426175.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|